OptimizeRx to Participate in Upcoming February Investor Conferences

Rhea-AI Summary

OptimizeRx Corp (Nasdaq: OPRX), a leading health technology provider, announced participation in two key conferences: the 11th Annual SVB Leerink Global Healthcare Conference on February 17 and the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 15. Will Febbo, CEO, will feature in a fireside chat at the SVB event, while the company will present at the BTIG conference. The leadership team will also be available for virtual one-on-one meetings to discuss their innovative point-of-care technology solutions.

ROCHESTER, Mich., Jan. 31, 2022 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on therapy announced today that members of its leadership team will attend and present at the upcoming 11th Annual SVB Leerink Global Healthcare Conference and BTIG’s MedTech, Digital Health, Life Science & Diagnostic Tools Conference.

Events Details

SVB Leerink, “11^Th Annual Global Healthcare Conference”

A fireside chat with Will Febbo, CEO, OptimizeRx:	February 17
Time:	10:00 AM ET

OptimizeRx’s leadership team will be available for virtual one-on-one meetings. For more information please visit: SVB Leerink.

BTIG, “MedTech, Digital Health, Life Science & Diagnostic Tools Conference”

Company presentation:	February 15
Time:	1:00 - 1:25 PM ET

OptimizeRx’s leadership team will be available for virtual one-on-one meetings. For more information please visit: BTIG.

About OptimizeRx
OptimizeRx is the best-in-class health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. Connecting over 60% of U.S. healthcare providers and millions of their patients through a technology platform embedded within a proprietary point-of-care network, OptimizeRx helps patients start and stay on their medications. 

For more information, follow the company on Twitter, LinkedIn or visit  www.optimizerx.com. 

Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates”, “believes”, “estimates”, “expects”, “forecasts”, “intends”, “plans”, “projects”, “targets”, “designed”, “could”, “may”, “should”, “will” or other similar words and expressions are intended to identify these forward-looking statements. All statements that reflect the Company’s expectations, assumptions, projections, beliefs or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to the Company’s growth, business plans and future performance. These forward-looking statements are based on the Company’s current expectations and assumptions regarding the Company’s business, the economy, and other future conditions. The Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise, except as required by applicable law. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition, and other risks summarized in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, its subsequent Quarterly Reports on Form 10-Q, and its other filings with the Securities and Exchange Commission.

OptimizeRx Contact 

Andy D’Silva, SVP Corporate Finance
adsilva@optimizerx.com 

Media Relations Contact 
Maira Alejandra, Media Relations Manager 
malejandra@optimizerx.com 

Investor Relations Contact
Ashley Robinson
LifeSci Advisors, LLC
arr@lifesciadvisors.com

FAQ

What events will OptimizeRx participate in February 2022?

OptimizeRx will attend the 11th Annual SVB Leerink Global Healthcare Conference on February 17 and the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on February 15.

Who will represent OptimizeRx at the SVB Leerink Conference?

Will Febbo, CEO of OptimizeRx, will be featured in a fireside chat at the SVB Leerink Conference.

What time is OptimizeRx's presentation at the BTIG Conference?

OptimizeRx's presentation at the BTIG Conference is scheduled for February 15 from 1:00 to 1:25 PM ET.

How can investors meet with OptimizeRx leadership during the conferences?

The leadership team of OptimizeRx will be available for virtual one-on-one meetings during both conferences.

What technology does OptimizeRx provide?

OptimizeRx offers point-of-care technology solutions that help patients initiate and maintain their medication therapies.